Extraction and Fractionation of M. platycalyx leaves
The air dried powdered leaves (5 kg) of M. platycalyx were extracted by maceration with 95% ethanol (3x, 5 L each) and then concentrated under reduced pressure to give (500 g) of a viscous residue. It was suspended in the least amount of distilled water (600 mL), transferred to a separating funnel and partitioned successively with light petroleum ether, dichloromethane (DCM) and ethyl acetate (EtOAc) (each solvent; 3x, 350 mL each). The obtained fractions were concentrated under reduced pressure using rotary evaporator to afford three fractions: petroleum ether (95 g), DCM (19 g), EtOAc (30 g). The remaining aqueous layer was concentrated to afford (250 g).
Preparation of Crude Polysaccharide (CP)
A part of the concentrated aqueous fraction (25 g) was gradually added to a flask containing one liter methanol with vigorous shaking and kept in a refrigerator overnight, then filtrated using Büchner funnel under reduced pressure. The residue was dried in the oven 40°C to yield (3 g) of crude polysaccharide powder.
In-vitro antimalarial activity
Antimalarial activity was estimated in-vitro against chloroquine sensitive (D 6 , Sierra Leone) and resistant (W 2 , Indo China) strains of Plasmodium falciparum by determining Plasmodial Lactate Dehydrogenase (PLDH) activity [16] . A 200 μL suspension of P. falciparum culture (2% parasitemia and 2% hematocrit in RPMI 1640 medium supplemented with 10% human serum and 60 μg/ mLAmikacin) was added to the wells of a 96-well plate containing 10 μL of serially diluted samples. The plate was flushed with a gas mixture of 90% N 2 , 5% O 2 and 5% CO 2 and incubated at 37°C for 72 h in a modular incubation chamber. PLDH activity was determined by using Malstat TM reagent (Flow Inc., Portland, OR). Briefly, 20 μL of the incubation mixture was mixed with 100 μL of the Malstat TM reagent and incubated for 30 min. Then, 20 μL of a 1:1 mixture of NBT/PES (Sigma, St. Louis, MO) was added and the plate is further incubated for an hour in dark. The reaction was stopped by adding 100 μL of a 5% acetic acid solution. The plate was measured at 650 nm using the EL-340 Biokinetics Reader (Bio-Tek Instruments, Vermont). IC 50 values were obtained from the dose-response curves generated by plotting percent growth versus drug concentration. Chloroquine was included in each assay as positive control. DMSO (0.25%) was used as a vehicle control. The TEE and different fractions of M. platycalyx leaves were initially tested against P. falciparum D 6 strain in a 1 ry phase screening at 15867 ng/mL and the percentage of inhibition was calculated relative to the negative and positive controls. The tested samples that resulted in % inhibition ≥ 50% proceeded to 2 nd assay.
In the 2 nd phase assay, the tested extract and fractions passing 1 st phase screening dissolved to 20 mg/mL and tested at three concentrations 47600, 15867, 5289 ng/mL and IC 50 were determined. The Selectivity Index (SI) was calculated. All ICs 50 were calculated using the XLfit curve. Artemisin and Chloroquine (standard antimalarial drugs) were used as positive controls. All experiments were carried out in duplicate. The results of the antimalarial activity were listed in tables 1 and 2. The in-vitro cytotoxicity was also determined against mammalian kidney fibroblasts (VERO cells). The assay was performed in 96-well tissue culture-treated plates as described earlier [17] . Briefly, cells were seeded in the wells of a 96well plate (25,000 cells/well) and incubated for 24 h. Samples were added and plates were again incubated for 48 h. The number of viable cells was determined by neutral red assay. IC50 values were determined from dose-response curves. Amphoterecin B was used as a positive control, while DMSO was used as vehicle control. The results were showed in table 2.
In-vitro antileishmanial activity
The antileishmanial activity of the TEE and different fractions of M. platycalyx leaves were tested in-vitro against a culture of Leishmania donovani promastigotes [18] . The promastigotes were grown in RPMI 1640 medium supplemented with 10% fetal calf 
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Copyright  Hamed ANE serum (Gibco Chem. Co.) at 26°C. A 3-day-old culture was diluted to 5×10 5 promastigotes/mL. Drug dilutions were prepared directly in cell suspension in 96-well plates. Plates were incubated at 26 o C for 48 h and growth of L. donovani promastigotes was determined by the Alamar blue assay. Standard fluorescence was measured on a Fluostar Galaxy plate reader (BMG Lab Technologies) at an excitation wavelength of 544 nm and an emission wavelength of 590 nm. Amphoterecin B was used as the standard antileishmanial agents. IC 50 values were computed from dose-response curves.
The tested samples that showed % inhibition ≥ 50% proceeded to 2 nd assay. In the 2 nd assay, the tested extract and fractions were dissolved to 20 mg/mL and tested at (40.0, 8.0 & 1.6 µg/mL). All ICs 50 and ICs 90 were calculated using the XLfit curve. The Amphotericin B (standard drug) was used as positive control [19, 20] . All experiments were carried out in duplicate. The results of the antileishmanial (1 ry phase) were listed in Table 3 .
Results and Discussion

Preliminary phytochemical screening
The TEE of M. platycalyx leaves showed the presence of carbohydrates and/or glycosides, flavonoids, unsaturated sterols and/ or triterpenes and anthraquinones. On the other hand, it was free from crystalline sublimate substances, saponins, alkaloids, tannins, cardenolides and coumarins. This preliminary phytochemical screening showed many classes of secondary metabolites indicating various expected biological activities.
In-vitro antimalarial activity
The petroleum ether fraction showed the highest percentage of inhibition (87%) against P. falciparum D 6 strain relative to chloroquine. Any drug caused ≥ 50% inhibition; it proceeded to 2 nd phase assay. On the other hand, the DCM fraction exhibited a good antimalarial activity 47% inhibition, followed by EtOAc fraction 24%, while the aqueous fraction showed weak activity 14%, but higher than that of the TEE (8%) as shown in Table 1 .
The 2 nd phase assay of the petroleum ether fraction ( Table 2) revealed IC 50 of 26760 ng/mL against P. falciparum D 6 and 22430 ng/ mL against P. falciparum W 2 . It did not show any cytotoxic activity against the VERO mammalian cells line up to the maximum dose tested; 47600 ng/mL, as recorded in Table 2 , indicating the safety of the petroleum ether fraction.
The previous phytochemical review showed various classes of compounds isolated and identified from genus Markhamia viz., phenylpropanoids, lignans, naphthoquinones, anthraquinones, sterols, cycloartane triterpenes and their glycoside derivatives, phenolic glycosides and triterpene acids. These compounds are isolated from different plant parts including roots, leaves, stem, root bark and heart wood [21] .
Moreover, sterols and triterpenes were found in the preliminary phytochemical screening of TEE. Consequently, petroleum ether has an ability to extract sterols and triterpenes from TEE. Therefore, the activity may be due to presence of sterols and triterpenes in this fraction [22, 23] . Our findings are in line with the previous studies [11, 13] .
In-vitro antileishmanial activity
The 1 ry phase screening of antileishmanial activity in Table  3 revealed that the DCM fraction was the most active against L. donovani amastigotes in THP1 with 86% inhibition, which is even higher than Amphotericin B. While, the other fractions showed weak or no activity. The DCM fraction in 2 nd phase assay showed IC 50 and IC 90 against L. donovani amastigote > 20 µg/mL. Leishmaniasis is a vector-borne disease, affecting 72 developing countries and 13 of the least developed countries. Visceral leishmaniasis due to L. donovani is the most severe form of Leishmania infections. The annual incidence of visceral leishmaniasis is estimated to be 500,000 cases. The overall prevalence of visceral leishmaniasis is 12 million people and the population at risk is 350 million [24] . The drug of choice for the treatment is still a problem. Therefore, there is an urgent need to discover new drugs with high activity and low side effects. Natural products have become a key source of new drugs in the last years [19, 25] .
As mentioned before, the earlier phytochemical review exhibited the presence of different classes of compounds isolated and identified from Markhamia species as phenyl propanoids, lignans, naphthoquinones, anthraquinones, sterols, cycloartane triterpenes and their glycoside derivatives, phenolic glycosides and triterpene acids [21] . Moreover, sterols and triterpenes were found in the preliminary phytochemical screening of TEE. Consequently, DCM has an ability to extract sterols and triterpenes from TEE. Therefore, the activity may be due to presence of sterols and triterpenes [20, 22] . Our results are in line with the previous studies on another two species [11, 13] . 
